Disproportionality analysis of satralizumab in FDA adverse event reporting system and Japanese adverse drug event report: a pharmacovigilance study.

Regarding the signal detection results, infection-related adverse events associated with satralizumab were highly significant and involved multiple organ systems as well as infectious complications ( Supplementary Table 3 ).

also in 132,142 other papers